Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 26, which means every article in Journal of Stem Cell Research & Therapy has got 26 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2022 2021 2020 2019 2018

Year wise published articles

59 65 23 13 36

Year wise citations received

351 405 380 349 319
Journal total citations count 3118
Journal Impact Factor 1.64
Journal 5 years Impact Factor 1.70
Journal CiteScore 11.56
Journal h-index 26
Important citations

Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations

Law and Economics of Personalized Medicine

Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?

Economic evaluations in paediatric dentistry clinical trials

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

Application of economic analysis to evaluate various infectious diseases in Vietnam

A systematic evaluation of paediatric allergy pathways in the West Midlands

Economic evaluation: its role and value for healthcare decision-making

Patient-Centered Approach to Benefit–Risk Characterization Using Number Needed to Benefit and Number Needed to Harm: Advanced Non–Small-Cell Lung Cancer

Economic Evaluation of Interventions in Parkinson’s disease - A Systematic Literature Review

Value-based health-care principles in health-care organizations

THE METAPHYSICAL-ETHICAL ERRORS OF PRISON PRIVATIZATION

Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists

How cost-effective is nutrition care delivered in primary healthcare settings? A systematic review of trial-based economic evaluations

MILITARY VETERAN TRANSITION INTO EMPLOYMENT AND CIVILIAN ENGAGEMENT: A WALKING WITH THE WOUNDED EVALUATION

Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

QUOTATIONS TO OPEN ON

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations

MODERN TREATMENT OF MULTIPLE MYELOMA IN RELAPSED AND REFRACTORY PATIENTS. CAN WE PAY THE PRICE?

MODERN TREATMENT OF MULTIPLE MYELOMA IN RELAPSED AND REFRACTORY PATIENTS. CAN WE PAY THE PRICE?